Table 1 |
||||
|
Patient characteristics |
||||
|
Case |
Sex/Age |
Location |
Pathology & Grade |
GADD45b positivity (%) |
|
|
||||
|
1 |
♂/43 |
Femur |
Enchondroma |
68.9 |
|
2 |
♂/16 |
Metatarsal |
Enchondroma |
81.6 |
|
3 |
♀/46 |
Phalanx |
Enchondroma |
74.4 |
|
4 |
♂/32 |
Phalanx |
Enchondroma |
83.5 |
|
5 |
♀/58 |
Femur |
Enchondroma |
66.6 |
|
6 |
♀/54 |
Phalanx |
Enchondroma |
68.8 |
|
7 |
♀/52 |
Femur |
CSA grade I |
67.3 |
|
8 |
♂/39 |
Pelvis |
CSA grade I |
55.5 |
|
9 |
♀/46 |
Femur |
CSA grade I |
44.6 |
|
10 |
♂/61 |
Femur |
CSA grade I |
49.2 |
|
11 |
♂/18 |
Tibia |
CSA grade I |
29.8 |
|
12 |
♂/67 |
Mandible |
CSA grade I |
38.1 |
|
13 |
♀/32 |
Pelvis |
CSA grade I |
31.0 |
|
14 |
♀/50 |
Femur |
CSA grade II |
11.8 |
|
15 |
♀/64 |
Rib |
CSA grade II |
3.9 |
|
16 |
♀/72 |
Femur |
CSA grade II |
14.8 |
|
17 |
♀/55 |
Pelvis |
CSA grade II |
5.9 |
|
18 |
♂/44 |
Femur |
CSA grade II |
11.9 |
|
19 |
♂/67 |
Mandible |
CSA grade II |
34.0 |
|
20 |
♂/61 |
Mandible |
CSA grade III |
3.8 |
|
|
||||
|
Zenmyo et al. Diagnostic Pathology 2010 5:69 doi:10.1186/1746-1596-5-69 |
||||
